GlaxoSmithKline
GSK
#217
Rank
ยฃ71.74 B
Marketcap
ยฃ35.52
Share price
-2.48%
Change (1 day)
30.09%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: ยฃ71.74 Billion

As of December 2025 GlaxoSmithKline has a market cap of ยฃ71.74 Billion. This makes GlaxoSmithKline the world's 217th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ71.74 B29.49%
2024ยฃ55.40 B-7.43%
2023ยฃ59.85 B0.66%
2022ยฃ59.46 B-26.44%
2021ยฃ80.82 B20.06%
2020ยฃ67.32 B-24.15%
2019ยฃ88.75 B19.93%
2018ยฃ74.00 B13.5%
2017ยฃ65.20 B-14.62%
2016ยฃ76.36 B14.24%
2015ยฃ66.84 B-0.09%
2014ยฃ66.90 B-14.45%
2013ยฃ78.21 B19.52%
2012ยฃ65.43 B-11.71%
2011ยฃ74.11 B12.28%
2010ยฃ66.00 B-2.59%
2009ยฃ67.76 B2.75%
2008ยฃ65.95 B-5.59%
2007ยฃ69.85 B-9.88%
2006ยฃ77.51 B-9.29%
2005ยฃ85.45 B16.61%
2004ยฃ73.28 B-0.45%
2003ยฃ73.61 B4.61%
2002ยฃ70.37 B-33.65%
2001ยฃ106.05 B-10.15%
2000ยฃ118.03 B87.5%
1999ยฃ62.94 B-16.92%
1998ยฃ75.77 B45.45%
1997ยฃ52.09 B58.47%
1996ยฃ32.87 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of GlaxoSmithKline was reported to be:

ยฃ72.45 Billion
by Nasdaq info icon info icon
ยฃ71.95 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
ยฃ209.26 B 191.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ108.21 B 50.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ181.85 B 153.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ188.89 B 163.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ87.72 B 22.27%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
ยฃ24.62 B-65.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
ยฃ0.96 B-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA